$TER — AVOID 📊 | 6 MONTHS THESIS

$TER — AVOID 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $1.3B | EPS $2.56 vs $2.12 🟢 | Margin 36.9% 💡 Consensus expected $2.12 EPS and strong growth, but the magnitude of the beat likely reset expectations higher. The variant view is that the market is underestimating how much of the positive cycle is already priced in, leaving stock vulnerable to even minor guidance disappointment as growth rates mean-revert. 📉 Reward/risk: 1.3:1 🏢 Business Quality: 8/10 - Teradyne holds a leading position in semiconductor test with high barriers to entry and sticky customer relationships, but the business is inherently cyclical and capex-dependent, capping its quality score below the absolute best. 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/TER0620

🎯 Q1 2026 | Rev $1.3B | EPS $2.56 vs $2.12 🟢 | Margin 36.9%